1887

Abstract

The SARS-CoV-2 pandemic continues to expand globally, with case numbers rising in many areas of the world, including the Indian sub-continent. Pakistan has one of the world’s largest populations, of over 200 million people and is experiencing a severe third wave of infections caused by SARS-CoV-2 that began in March 2021. In Pakistan, during the third wave until now only 12 SARS-CoV-2 genomes have been collected and among these nine are from Islamabad. This highlights the need for more genome sequencing to allow surveillance of variants in circulation. In fact, more genomes are available among travellers with a travel history from Pakistan, than from within the country itself. We thus aimed to provide a snapshot assessment of circulating lineages in Lahore and surrounding areas with a combined population of 11.1 million. Within a week of April 2021, 102 samples were sequenced. The samples were randomly collected from two hospitals with a diagnostic PCR cutoff value of less than 25 cycles. Analysis of the lineages shows that the Alpha variant of concern (first identified in the UK) dominates, accounting for 97.9 % (97/99) of cases, with the Beta variant of concern (first identified in South Africa) accounting for 2.0 % (2/99) of cases. No other lineages were observed. In depth analysis of the Alpha lineages indicated multiple separate introductions and subsequent establishment within the region. Eight samples were identical to genomes observed in Europe (seven UK, one Switzerland), indicating recent transmission. Genomes of other samples show evidence that these have evolved, indicating sustained transmission over a period of time either within Pakistan or other countries with low-density genome sequencing. Vaccines remain effective against Alpha, however, the low level of Beta against which some vaccines are less effective demonstrates the requirement for continued prospective genomic surveillance.

Funding
This study was supported by the:
  • Biotechnology and Biological Sciences Research Council (Award BB/R012504/1)
    • Principle Award Recipient: NotApplicable
  • Higher Education Commission, Pakistan (Award RRG-211)
    • Principle Award Recipient: NotApplicable
  • Biotechnology and Biological Sciences Research Council (Award BB/CCG1860/1)
    • Principle Award Recipient: NotApplicable
  • Biotechnology and Biological Sciences Research Council (Award BBS/E/F/000PR10352)
    • Principle Award Recipient: NotApplicable
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000693
2021-11-30
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/mgen/7/11/mgen000693.html?itemId=/content/journal/mgen/10.1099/mgen.0.000693&mimeType=html&fmt=ahah

References

  1. Sarwar MB, Yasir M, Alikhan N-F, Afzal N, Oliveira Martins L de. SARS- cov- 2 variants of concern dominate in lahore, Pakistan in april 2021 Figshare 2021 [View Article]
    [Google Scholar]
  2. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506 [View Article] [PubMed]
    [Google Scholar]
  3. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20:533–534 [View Article] [PubMed]
    [Google Scholar]
  4. Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Euro Surveill 2020; 25:2001410 [PubMed]
    [Google Scholar]
  5. Hodcroft EB, Hadfield J, Neher RA, Bedford T. Year-letter Genetic Clade Naming for SARS-CoV-2 on Nextstrain.org; 2020 https://nextstrain.org/blog/2020-06-02-SARSCoV2-clade-naming
  6. Rambaut A. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 2020; 5:1403–1407 [View Article] [PubMed]
    [Google Scholar]
  7. Transmission of SARS-COV-2 lineage b.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv [Preprint] 2021 [View Article]
    [Google Scholar]
  8. Tegally H. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 2021; 592:438–443 [View Article] [PubMed]
    [Google Scholar]
  9. National Command Operation Center Pakistan Cases Details; 2021 https://covid.gov.pk/stats/pakistan
  10. Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data – from vision to reality. Euro Surveill 2017; 22:30494 [View Article] [PubMed]
    [Google Scholar]
  11. Quick J. NCOV-2019 sequencing protocol v2 v1. protocolsIoBDP7I5RN 2020 [View Article]
    [Google Scholar]
  12. Baker DJ. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes. Genome Med 2021; 13:21 [View Article] [PubMed]
    [Google Scholar]
  13. Artic network; 2018 https://artic.network/ accessed 6 July 2020
  14. Krueger F. Trim Galore UK: The Babraham Institute; 2020 https://github.com/FelixKrueger/TrimGalore
  15. Li H. arXiv:1303.3997 USA: Cornell University; 2013 http://arxiv.org/abs/1303.3997
  16. Grubaugh ND. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol 2019; 20:8 [View Article] [PubMed]
    [Google Scholar]
  17. O’Toole Á. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol 2021; 7:veab064 [View Article] [PubMed]
    [Google Scholar]
  18. Sekizuka T. COVID-19 genome surveillance at international airport quarantine stations in Japan. J Travel Med 2021; 28:taaa217 [View Article] [PubMed]
    [Google Scholar]
  19. de Oliveira Martins L. Uvaia UK: Quadram Institute Bioscience; 2021 https://github.com/quadram-institute-bioscience/uvaia
  20. Turakhia Y. Stability of SARS-CoV-2 phylogenies. PLoS Genet 2020; 16:e1009175 [View Article] [PubMed]
    [Google Scholar]
  21. Minh BQ, Klaere S, von Haeseler A. Phylogenetic diversity within seconds. Syst Biol 2006; 55:769–773 [View Article]
    [Google Scholar]
  22. Simonsen M, Pedersen CNS. Rapid computation of distance estimators from nucleotide and amino acid alignments, in proceedings of the 2011 ACM symposium on applied computing - SAC 11. the 2011 ACM symposium. In Proceedings of the ACM Symposium on Applied Computing TaiChung, Taiwan: ACM Press; 2011 p 89
    [Google Scholar]
  23. Minh BQ. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 2020; 37:1530–1534 [View Article] [PubMed]
    [Google Scholar]
  24. Hoang DT. UFBoot2: Improving the Ultrafast Bootstrap Approximation. Mol Biol Evol 2018; 35:518–522 [View Article] [PubMed]
    [Google Scholar]
  25. Sagulenko P, Puller V, Neher RA. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol 2018; 4:vex042 [View Article] [PubMed]
    [Google Scholar]
  26. Louca S, Doebeli M. Efficient comparative phylogenetics on large trees. Bioinformatics 2018; 34:1053–1055 [View Article]
    [Google Scholar]
  27. Yu G, Smith DK, Zhu H, Guan Y, Lam T-Y. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods in Ecology and Evolution Edited by G McInerny 2017; 8:28–36 [View Article]
    [Google Scholar]
  28. du Plessis L. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science 2021; 371:708–712 [View Article] [PubMed]
    [Google Scholar]
  29. Javed B. Is Pakistan’s response to coronavirus (SARS-CoV-2) adequate to prevent an outbreak?. Front Med (Lausanne) 2020; 7:158 [View Article] [PubMed]
    [Google Scholar]
  30. Galloway SE. Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021’, MMWR. MMWR Morb Mortal Wkly Rep 2021; 70:95–99 [View Article] [PubMed]
    [Google Scholar]
  31. Abu-Raddad LJ, Chemaitelly H, Butt AA. National Study Group for COVID-19 Vaccination Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med 2021; 385:187–189 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000693
Loading
/content/journal/mgen/10.1099/mgen.0.000693
Loading

Data & Media loading...

Supplements

Loading data from figshare Loading data from figshare
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error